(Q39283211)

English

Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

scientific article published on 25 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

steatohepatitis

0 references

0 references

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Robert J Wong

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Ramsey Cheung

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Aijaz Ahmed

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

language of work or name

0 references

publication date

25 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

59

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

2188-2195

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Nonalcoholic fatty liver disease: a review of current understanding and future impact

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Nonalcoholic fatty liver disease and liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

21 January 2018

Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

7 January 2021

based on heuristic

inferred from DOI database lookup

Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26986

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.26986

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

release_ggnqcechwveelfvo5zhbulfwne

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39283211&oldid=1500923640"